Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.

Kidney international - 1 Jan 2000

Perna A, Ruggenenti P, Testa A, Spoto B, Benini R, Misefari V, Remuzzi G, Zoccali C

Abstract excerpt

UNLABELLED: ACE genotype and ACE induced renoprotection in chronic proteinuric nephropathies. BACKGROUND: Whether angiotensin-converting enzyme (ACE) gene polymorphism affects disease progression and response to ACE inhibitor therapy in nondiabetic proteinuric nephropathies is not clearly established. METHODS: The relationship between insertion/deletion (I/D) genotypes and proteinuria, rate of glomerular...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiotensin-Converting Enzyme Inhibitors
Share to Base Sequence

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA Primers

Share to Genotype

Share to Glomerular Filtration Rate

Share to Kidney Failure, Chronic

Share to Peptidyl-Dipeptidase A

Share to Proteinuria

Source

Identifiers

PMID: 10620209
DOI: 10.1046/j.1523-1755.2000.00818.x

Genes

ACE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1.PMID 10620209Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and renoprotection in diabetic and nondiabetic nephropathies.Semantic proximity Read ↗

Long-term renoprotective effects of losartan in diabetic nephropathy: interaction with ACE insertion/deletion genotype?Semantic proximity Read ↗

Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.Semantic proximity Read ↗

ACE genotype and ACE inhibitor response in kidney disease: a perspective.Semantic proximity Read ↗

Effect of angiotensin-converting enzyme (ACE) gene polymorphism on progression of renal disease and the influence of ACE inhibition in IDDM patients: findings from the EUCLID Randomized Controlled Trial. EURODIAB Controlled Trial of Lisinopril in IDDM.Semantic proximity Read ↗

Proteinuria and angiotensin converting enzyme (ACE) gene polymorphism.Semantic proximity Read ↗

Impact of angiotensin-converting enzyme gene polymorphism on proteinuria and arterial hypertension.Semantic proximity Read ↗

Association between angiotensin-converting-enzyme gene polymorphism and failure of renoprotective therapy.Semantic proximity Read ↗

Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.Semantic proximity Read ↗

Antiproteinuric effect of losartan in non-diabetic renal disease is not dependent on ACE insertion/deletion polymorphism.Semantic proximity Read ↗

ACE DD genotype is more susceptible than ACE II and ID genotypes to the antiproteinuric effect of ACE inhibitors in patients with proteinuric non-insulin-dependent diabetes mellitus.Semantic proximity Read ↗

Different Mechanisms for the Progression of CKD with ACE Gene Polymorphisms.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.